View in EDS HTML Full Text PDF Full Text

Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.

Saved in:
Bibliographic Details
Title: Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.
Authors: Kuang AG; Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA., Shatila M; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah JS; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Mittal N; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Naz S; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ebinama U; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA., Iyer SP; Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Strati P; Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shafi MA; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thomas AS; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang HC; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Y; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1466, Houston, TX 77030, USA.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Feb 15; Vol. 18, pp. 17588359261417635. Date of Electronic Publication: 2026 Feb 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41705138
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kuang+AG%22">Kuang AG</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Shatila+M%22">Shatila M</searchLink>; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shah+JS%22">Shah JS</searchLink>; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mittal+N%22">Mittal N</searchLink>; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Naz+S%22">Naz S</searchLink>; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ebinama+U%22">Ebinama U</searchLink>; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+SP%22">Iyer SP</searchLink>; Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Strati+P%22">Strati P</searchLink>; Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Shafi+MA%22">Shafi MA</searchLink>; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+AS%22">Thomas AS</searchLink>; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+HC%22">Zhang HC</searchLink>; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Division of Internal Medicine, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1466, Houston, TX 77030, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101510808%22">Therapeutic advances in medical oncology</searchLink> [Ther Adv Med Oncol] 2026 Feb 15; Vol. 18, pp. 17588359261417635. <i>Date of Electronic Publication: </i>2026 Feb 15 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101510808 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1758-8340 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217588340%22">17588340 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Med Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41705138
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17588359261417635
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17588359261417635
    Titles:
      – TitleFull: Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kuang AG
      – PersonEntity:
          Name:
            NameFull: Shatila M
      – PersonEntity:
          Name:
            NameFull: Shah JS
      – PersonEntity:
          Name:
            NameFull: Mittal N
      – PersonEntity:
          Name:
            NameFull: Naz S
      – PersonEntity:
          Name:
            NameFull: Ebinama U
      – PersonEntity:
          Name:
            NameFull: Iyer SP
      – PersonEntity:
          Name:
            NameFull: Strati P
      – PersonEntity:
          Name:
            NameFull: Shafi MA
      – PersonEntity:
          Name:
            NameFull: Thomas AS
      – PersonEntity:
          Name:
            NameFull: Zhang HC
      – PersonEntity:
          Name:
            NameFull: Wang Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 02
              Text: 2026 Feb 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1758-8340
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in medical oncology
              Type: main
ResultId 1